Although antiretroviral therapy (ART) has prolonged survival in HIV-infected persons, an increase in cardiovascular disease (CVD) has been observed. A frequent complication of ART is the development of lipodystrophy (LD) that may be associated with CVD. We assessed the contribution of chronic HIV infection, ART use and LD to the presence and extent of subclinical atherosclerosis as evaluated by coronary artery calcium imaging.
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS / Guaraldi, Giovanni; N., Alexopoulos; Stentarelli, Chiara; Zona, Stefano; Orlando, Gabriella; Carli, Federica; Ligabue, Guido; A., Lattanzi; Rossi, Rosario; Mc, Modena; F., Palella; P., Raggi. - In: ATHEROSCLEROSIS SUPPLEMENTS. - ISSN 1567-5688. - STAMPA. - 10:(2009), pp. e960-e960. (Intervento presentato al convegno XV International Symposium on Atherosclerosis tenutosi a Boston, MA, USA nel June 14-18, 2009).
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS
GUARALDI, Giovanni;STENTARELLI, Chiara;ZONA, Stefano;ORLANDO, Gabriella;CARLI, FEDERICA;LIGABUE, Guido;ROSSI, Rosario;
2009
Abstract
Although antiretroviral therapy (ART) has prolonged survival in HIV-infected persons, an increase in cardiovascular disease (CVD) has been observed. A frequent complication of ART is the development of lipodystrophy (LD) that may be associated with CVD. We assessed the contribution of chronic HIV infection, ART use and LD to the presence and extent of subclinical atherosclerosis as evaluated by coronary artery calcium imaging.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
